LNSR

LENSAR, Inc.

Healthcare · Medical Devices

$98.62 sample

+0.43 (+0.44%) 1D

Market cap

$270.9B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-08

Alerts

8

Price$98.62 +11.55% 3M daily closessample

99.8188.41

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider sell: General Counsel
Oct 08SECForm 144 filed
Oct 05INSInsider buy: EVP, Operations
Sep 28INSInsider sell: Chief Financial Officer
Sep 22INSInsider sell: EVP, Operations
Sep 17SECForm 144 filed
Sep 11SECDEF 14A filed
Sep 08INSInsider sell: EVP, Operations

Sign up to see the real LNSR record →

Company facts

SEC EDGAR registration

Name: LENSAR, Inc.
Sector: Healthcare
Industry: Medical Devices
Smart-money score: +51sample, -100 to +100
Reporting currency: USD

Who is positioning in LNSR

sample

Insiders: 25 insider transactions over 90 days, net selling, $742.9M
Congress: No member trades over 90 days
Institutions · 13F: 17 funds hold $4.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$7.9B +13.5% y/y

Q4 2024Q3 2026

Inventory$4.8B +18.4% y/y

Q4 2024Q3 2026

Accounts receivable$3.6B +6.2% y/y

Q4 2024Q3 2026

Total debt$9.7B +11.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $80.3B -6.7% 3M
Sample peer B: $145.5B +16.1% 3M
Sample peer C: $132.4B +12.7% 3M
Sample peer D: $160.0B +13.8% 3M
Sample peer E: $156.4B -8.9% 3M